ReguGene Co., Ltd. is a pharmaceutical venture company founded on 3rd Sep 2018 by Professor Hiroshi Sugiyama at Graduate School of Science of Kyoto University and Professor Yasuhiko Kamikubo at Graduate School of Medicine of Kyoto University. Our aim is to supply medicines for intractable and rare diseases by developing DNA-targeting drugs utilizing cell permeable pyrrole-imidazole polyamides.
|Stockholders||Prof. Hiroshi Sugiyama, Prof. Yasuhiko Kamikubo, Prof. NAMASIVAYAM Ganesh Pandian, Shinsuke Sato, and Dr. Vaijayanthi THANGAVEL|
|Scientific Advisory Board||Prof. Hiroshi Sugiyama, Prof. Yasuhiko Kamikubo, Prof. NAMASIVAYAM Ganesh Pandian|
|Representative||Dr. Vaijayanthi THANGAVEL|